Range
17.98 - 19.08
Vol / Avg.
177.3K/664.2K
Div / Yield
-
52 Wk
17.29 - 36.48
Mkt Cap
1.1B
Payout Ratio
-
Open
18.84
P/E
-
EPS
-0.86
Shares
61.3M
Outstanding
61.3M
Total Float
59.7M
Benzinga - Oct 1, 2021, 7:43AM
Benzinga - Sep 7, 2021, 4:26PM
load more
Sector: Health Care.Industry: Biotechnology
Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. The company's strategy includes leveraging partnerships with a therapeutic focus geared toward developing a broad portfolio of pipeline candidates. The company also targets autoimmune disorders and infectious diseases. The company's intellectual property is characterized by its patent use to protect the composition of its product candidates and the technology used to create them.

Earnings

see more
Q4 2021Est.ActualSurprise
EPS
(EXPECTED)2022-02-24
REV
Q3 2021Est.ActualSurprise
EPS-0.690-0.860 -0.1700
REV15.662M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Macrogenics Questions & Anwsers

Q

How do I buy Macrogenics (MGNX) stock?

A

You can purchase shares of Macrogenics (NASDAQ: MGNX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Macrogenics's (MGNX) competitors?

Q

What is the target price for Macrogenics (MGNX) stock?

A

The latest price target for Macrogenics (NASDAQ: MGNX) was reported by JMP Securities on November 3, 2021. The analyst firm set a price target for 38.00 expecting MGNX to rise to within 12 months (a possible 112.17% upside). 9 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Macrogenics (MGNX)?

A

The stock price for Macrogenics (NASDAQ: MGNX) is $17.91 last updated Today at 8:33:42 PM.

Q

Does Macrogenics (MGNX) pay a dividend?

A

There are no upcoming dividends for Macrogenics.

Q

When is Macrogenics (NASDAQ:MGNX) reporting earnings?

A

Macrogenics’s $Q4 earnings are confirmed for after-market on February 24, 2022.

Q

Is Macrogenics (MGNX) going to split?

A

There is no upcoming split for Macrogenics.

Q

What sector and industry does Macrogenics (MGNX) operate in?

A

Macrogenics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.